At the time of this writing, more than 3.3 million individuals have been diagnosed with COVID-19, and more than 222,000 have died from the...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
In an extraordinary turn of events, the American Association for Cancer Research (AACR) Annual Meeting 2020 kicked off Monday...
One in three cancer survivors reports that they or their partners have stayed in jobs due to concerns about...
A study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival and other...
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is...
“These are extraordinary times,” began Hugh Auchincloss, MD, as he opened up the recent NIH-AACR Cancer, Autoimmunity, and Immunology...
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
Cancer patients and survivors share tips on how to respond to the coronavirus pandemic, and more news of the...